The Lancet Oncology in conversation with
David J Pinato on SARS-CoV-2 omicron outcomes among patients with cancer
Donnerstag, 30. Juni 2022 · 5 min
Kapitelklicken springt direkt hin
Shownotes
David J Pinato (Imperial College London, London, UK) discusses the OnCovid registry study on the outcomes of the SARS-CoV-2 omicron variant outbreak among patients with cancer in Europe.
Read the full article:
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe (thelancet.com/journals/lanonc/article/PIIS1470…)00273-X/fulltext)
Tell us what you thought about this episode (buzzsprout.com/1391338/fan_mail/new)
Continue this conversation on social!
Follow us today at...
facebook.com/thelancetmedicaljournal
linkedIn.com/company/the-lancet (linkedin.com/company/the-lancet)